Skip to content

Study on the standardization and clinical evaluation of the technique of cheek acupuncture for the treatment of stable coronary artery disease

Study on the standardization and clinical evaluation of the technique of cheek acupuncture for the treatment of stable coronary artery disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300072883
Enrollment
Unknown
Registered
2023-06-27
Start date
2023-06-30
Completion date
Unknown
Last updated
2023-07-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stable coronary artery disease

Interventions

Treatment group:Cheek needle acupuncture + Conventional drug treatment

Sponsors

Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
45 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Age between 45-80 years old, gender is not limited (2) Also meet the western medical diagnostic criteria for coronary heart disease (3) Those who have given informed consent and signed the informed consent form

Exclusion criteria

Exclusion criteria: 1. Acute myocardial infarction, unstable angina, combined with other cardiac diseases or severe cardiac insufficiency (New York Heart Association cardiac function class > III) and poorly controlled hypertension after standard treatment (blood pressure > 170/105 mm Hg) 2. Combination of brain, liver, kidney, hematopoietic system and other serious primary diseases 3. Patients with severe psychiatric disorders such as hallucinations, delusions, panic and suicidal behavior 4. Combined with menopausal syndrome, neurosis, hyperthyroidism, etc. 5. Pregnant or preparing for pregnancy and lactating women 6. Within the last 3 months, have received other new drug clinical trials 7. Suspected or confirmed history of alcohol or drug abuse, or other circumstances that, in the judgment of the investigator, reduce the likelihood of enrollment or complicate enrollment, such as frequent changes in the work environment that could result in missed visits 8. Known to be allergic to metals

Design outcomes

Primary

MeasureTime frame
electrocardiogram;Assessment of anxiety symptoms;Frequency of angina attacks;

Secondary

MeasureTime frame
Quality of life score;Pittsburgh sleep quality index;

Countries

China

Contacts

Public ContactWu Bo

Affiliated Hospital of Shandong University of Traditional Chinese Medicine

wubojinan@163.com+86 186 6019 9889

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026